MiNA Therapeutics
Clinical stage biotechnology company pioneering RNA activation based medicines
Total raised
€25M
€24,911,300
Funding rounds
1
Investors
1
distinct backers
Active since
2020-09
latest 2020-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-10 | Series A | €25M | aMoon Fund | View deal → |